PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'C.S. Mott Children\'s Hospital, University of Michigan, Ann Arbor, Michigan, USA.\', \'T1D Exchange, Boston, Massachusetts, USA.\', \'University of Florida, Gainesville, Florida, USA.\', \'Rady Children\'s Hospital/University of California, San Diego, California, USA.\', \'Cincinnati Children\'s Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.\', \'University of Miami Miller School of Medicine, Miami, Florida, USA.\', \'SUNY Upstate Medical University, Syracuse, New York, USA.\', \'Lucile Packard Children\'s Hospital/Stanford University, Palo Alto, California, USA.\', \'Barbara Davis Center, University of Colorado, Aurora, Colorado, USA.\', \'Nationwide Children\'s Hospital, Columbus, Ohio, USA.\', \'Texas Children\'s Hospital, Baylor College of Medicine, Houston, Texas, USA.\', \'University of Washington, Seattle, Washington, USA.\', \'Bower School of Population Health, University of Mississippi Medical Center, Jackson, Mississippi, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1089/dia.2021.0080
?:hasPublicationType
?:journal
  • Diabetes technology & therapeutics
is ?:pmid of
?:pmid
?:pmid
  • 33851873
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Adoption of Telemedicine for Type 1 Diabetes Care During the COVID-19 Pandemic.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all